167 related articles for article (PubMed ID: 33973962)
1. Colorectal Neoplasia Detection in Individuals With Positive Multitarget Stool DNA Tests: Data From the New Hampshire Colonoscopy Registry.
Anderson JC; Robinson CM; Hisey WM; Edwards DK; Kneedler BL; Berger BM; Butterly LF
J Clin Gastroenterol; 2022 May-Jun 01; 56(5):419-425. PubMed ID: 33973962
[TBL] [Abstract][Full Text] [Related]
2. Colonoscopy Findings in FIT+ and mt-sDNA+ Patients versus in Colonoscopy-only Patients: New Hampshire Colonoscopy Registry Data.
Anderson JC; Robinson CM; Hisey W; Limburg PJ; Butterly LF
Cancer Prev Res (Phila); 2022 Jul; 15(7):455-464. PubMed ID: 35378546
[TBL] [Abstract][Full Text] [Related]
3. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
Prince M; Lester L; Chiniwala R; Berger B
World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
[TBL] [Abstract][Full Text] [Related]
4. Serrated Polyp Yield at Colonoscopy in Patients with Positive FIT, Positive mt-sDNA, and Colonoscopy Only: Data from the New Hampshire Colonoscopy Registry.
Anderson JC; Hisey WM; Robinson CM; Limburg PJ; Kneedler BL; Butterly LF
Cancer Epidemiol Biomarkers Prev; 2023 Feb; 32(2):226-232. PubMed ID: 36409472
[TBL] [Abstract][Full Text] [Related]
5. Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy.
Eckmann JD; Ebner DW; Bering J; Kahn A; Rodriguez E; Devens ME; Lowrie KL; Doering K; Then S; Burger KN; Mahoney DW; Prichard DO; Wallace MB; Gurudu SR; Finney LJ; Limburg P; Berger B; Ahlquist DA; Kisiel JB
Am J Gastroenterol; 2020 Apr; 115(4):608-615. PubMed ID: 32068535
[TBL] [Abstract][Full Text] [Related]
6. Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of Testing.
Voss JK; Ebner DW; Burger KN; Mahoney DW; Devens ME; Lowrie KL; Kisiel JB
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2399-2406. PubMed ID: 36621751
[TBL] [Abstract][Full Text] [Related]
7. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests.
Pickhardt PJ; Correale L; Hassan C
AJR Am J Roentgenol; 2021 Oct; 217(4):817-830. PubMed ID: 33703913
[No Abstract] [Full Text] [Related]
8. Influence of Colorectal Cancer Risk Factors on Predictive Value of a Positive Multitarget Stool DNA Test.
Narayani KR; Narayani RI
J Clin Gastroenterol; 2024 May-Jun 01; 58(5):471-474. PubMed ID: 37389965
[TBL] [Abstract][Full Text] [Related]
9. Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes.
Fendrick AM; Fisher DA; Saoud L; Ozbay AB; Karlitz JJ; Limburg PJ
Cancer Prev Res (Phila); 2021 Sep; 14(9):845-850. PubMed ID: 34021023
[TBL] [Abstract][Full Text] [Related]
10. Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA.
Ebner DW; Eckmann JD; Burger KN; Mahoney DW; Bering J; Kahn A; Rodriguez EA; Prichard DO; Wallace MB; Kane SV; Finney Rutten LJ; Gurudu SR; Kisiel JB
Clin Transl Gastroenterol; 2021 Jun; 12(6):e00375. PubMed ID: 34140458
[TBL] [Abstract][Full Text] [Related]
11. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
Berger BM; Schroy PC; Dinh TA
Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
13. Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening.
Redwood DG; Blake ID; Provost EM; Kisiel JB; Sacco FD; Ahlquist DA
J Prim Care Community Health; 2019; 10():2150132719884295. PubMed ID: 31646933
[No Abstract] [Full Text] [Related]
14. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of Multitarget Stool DNA and CT Colonography for Noninvasive Colorectal Cancer Screening.
Pickhardt PJ; Graffy PM; Weigman B; Deiss-Yehiely N; Hassan C; Weiss JM
Radiology; 2020 Oct; 297(1):120-129. PubMed ID: 32779997
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U; Mannalithara A
Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
[TBL] [Abstract][Full Text] [Related]
17. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing.
Berger BM; Parton MA; Levin B
Am J Manag Care; 2016 Feb; 22(2):e77-81. PubMed ID: 26881323
[TBL] [Abstract][Full Text] [Related]
18. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667
[TBL] [Abstract][Full Text] [Related]
19. The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.
Ebner D; Kisiel J; Barnieh L; Sharma R; Smith NJ; Estes C; Vahdat V; Ozbay AB; Limburg P; Fendrick AM
J Med Econ; 2023; 26(1):1219-1226. PubMed ID: 37752872
[TBL] [Abstract][Full Text] [Related]
20. Positive Predictive Value for Multitarget Stool DNA After Bariatric and Metabolic Surgery.
Ebner DW; Burger KN; Broderick B; Mahoney DW; Kellogg TA; Acosta A; Kisiel JB
Gastro Hep Adv; 2023; 2(7):902-910. PubMed ID: 37876832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
